Hangzhou Adamerck Pharmlabs
Latest round
- Series B
Last raised
- Aug 2021
Total raised
- $46M
Investors
- 5
About Hangzhou Adamerck Pharmlabs
Based in Zhejiang, China and founded in 2000, Hangzhou Adamerck Pharmlabs Inc. is a pharmaceutical enterprise, being dedicated to the research and development of innovative drug. The company was founded by Youmao Qi, a Doctor returned from overseas. Up to now, the company has declared more than 25 domestic patents for invention and 3 international patents for invention, developed 5 new drugs in State Category 1, and accomplished the registration of more than 100 projects to CFDA. Adamerck has established research and development center and academician workstation including the screening platform for chemical drugs, natural drugs and medicinal preparations. The company also has a drug manufacturing base which is able to process APIs, solid preparations and injections. Muscle relaxant antagonist Aom0498 is the company first independent target muscle relaxant, which has entered the clinical trial stage. It is helpful for patients to restore spontaneous breathing after operation, it can also used to reduce side effects and emergency rescue. The company also has other new drug projects such as Anti-thrombotic Aom0315, Intravenous anesthetic Aom0765 and Weight-Loss Drug Aom1110. The company's research involves drugs for anesthesia, cardiovascular system, weight loss, diabetes, hypnosis and tumor.
Who invested in Hangzhou Adamerck Pharmlabs
5 investors across 1 round
See all investors in Hangzhou Adamerck Pharmlabs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 25, 2021
Amount
$46M
Investors
Questions about Hangzhou Adamerck Pharmlabs
Who invested in Hangzhou Adamerck Pharmlabs?
Hangzhou Adamerck Pharmlabs has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hangzhou Adamerck Pharmlabs raised?
Hangzhou Adamerck Pharmlabs has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hangzhou Adamerck Pharmlabs last raise money?
Hangzhou Adamerck Pharmlabs's most recent round on record is a Series B, in Aug 2021.
What does Hangzhou Adamerck Pharmlabs do?
Based in Zhejiang, China and founded in 2000, Hangzhou Adamerck Pharmlabs Inc.
Where is Hangzhou Adamerck Pharmlabs headquartered?
Hangzhou Adamerck Pharmlabs is headquartered in Hangzhou, China.
Which VCs invest in companies like Hangzhou Adamerck Pharmlabs?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Hangzhou Adamerck Pharmlabs's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Hangzhou Adamerck Pharmlabs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.